Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNP-2092 in Liver Cirrhosis with Hyperammonemia
NCT06135675Phase 2Completed
- Sponsor
- TenNor Therapeutics
- Start
- Aug 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifaquizinone in hyperammonemia, hepatic encephalopathy (HE), sponsored by TenNor Therapeutics. Started Aug 2020; status: completed.
02
Drugs
rifaquizinone
03
Conditions
hyperammonemiahepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT06135675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06135675.